Vitalhub (TSE:VHI) Given a C$13.50 Price Target at Raymond James

Raymond James set a C$13.50 price target on Vitalhub (TSE:VHI) in a research note released on Thursday,BayStreet.CA reports. The brokerage currently has an outperform rating on the stock.

VHI has been the subject of several other research reports. Canaccord Genuity Group boosted their price objective on shares of Vitalhub from C$12.00 to C$12.50 and gave the stock a “buy” rating in a research report on Thursday, January 16th. Scotiabank set a C$14.00 price target on shares of Vitalhub and gave the stock an “outperform” rating in a research note on Thursday, January 30th. Five equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of C$11.92.

Vitalhub Stock Performance

Shares of TSE VHI opened at C$9.66 on Thursday. The stock’s 50-day simple moving average is C$10.49 and its 200-day simple moving average is C$10.31. The firm has a market capitalization of C$522.53 million, a PE ratio of 157.12, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26. Vitalhub has a fifty-two week low of C$5.80 and a fifty-two week high of C$12.09.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.